CaparelloC., “Fixed-Dose Rate Gemcitabine Plus Capecitabine as Second-Line Treatment for Metastatic Pancreatic Cancer Patients Pretreated with Oxaliplatin”, JOP, vol. 13, no. 5S, p. 596, Sep. 2012.